104 results
8-K
EX-99.1
KRYS
Krystal Biotech Inc
26 Feb 24
Krystal Biotech Announces Fourth Quarter and Full Year 2023
8:04am
statistical data made by independent parties and by the Company that involves a number of assumptions and limitations. Neither the Company nor any
S-8
EX-23.1
KRYS
Krystal Biotech Inc
26 Feb 24
Registration of securities for employees
7:59am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our reports dated February 26, 2024, with respect
S-8
KRYS
Krystal Biotech Inc
26 Feb 24
Registration of securities for employees
7:59am
, independent public accounting firm.
Consent of Mayer Hoffman McCann P.C., independent public accounting firm.
Consent of Morrison & Foerster LLP (included
S-8
EX-23.2
18l1xy0x5az
26 Feb 24
Registration of securities for employees
7:59am
8-K
EX-99.2
wbsgp q1qrm2sumkqj
26 Jul 23
Krystal Biotech Announces Pipeline Expansion into Oncology
4:01pm
S-3ASR
3gd0eak
18 Jul 23
Automatic shelf registration
4:05pm
S-3ASR
EX-23.1
9b0j2
18 Jul 23
Automatic shelf registration
4:05pm
S-3ASR
EX-23.2
ctkmqjc
18 Jul 23
Automatic shelf registration
4:05pm
8-K
fjictllmo 7f3
23 May 23
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
EX-10.2
63hlyj
22 May 23
Krystal Biotech Announces $160 Million Private Placement Equity Financing
7:32am
8-K
EX-10.1
p3gpxr
22 May 23
Krystal Biotech Announces $160 Million Private Placement Equity Financing
7:32am
8-K
EX-1.1
krztl14
8 May 23
Entry into a Material Definitive Agreement
8:51am
424B5
co2e75gysp2hs
8 May 23
Prospectus supplement for primary offering
8:48am
S-3ASR
5u2sxx aux5g9ufpjv
6 Apr 23
Automatic shelf registration
4:43pm
S-3ASR
EX-23.2
uo43uys
6 Apr 23
Automatic shelf registration
4:43pm